Clinical trial
Evaluation of LOXL1 Polymorphism in Pseudoexfoliation Syndrome in the Korean Population
NCT01515735 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of LOXL1 Polymorphism in Pseudoexfoliation Syndrome in the Korean Population
- Lead sponsor
- Samsung Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 31, 2011
- Completion date
- December 31, 2012
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pseudoexfoliation syndrome